Scarring, arising as a natural reaction to surgery performed to improve an underlying ophthalmic problem such as glaucoma, can cause significant impairment of vision. Our site has one of the strongest track records in the world in the fields of preventing ocular scarring, promoting cell regeneration and developing novel medicines. The overarching aim of this research theme is to accelerate the availability and range of innovative cellular and molecular therapies which meet many unmet needs in ophthalmology and in the human body.
- to develop novel stem cell therapies to prevent blindness and/or restore vision caused by AMD, ocular surface disease, glaucoma and diabetes.
- to develop novel therapies to prevent scarring and promote healthy cell regeneration for diseases and traumas that affect the front and back of the eye.
- to develop novel delivery mechanisms (eg. tablet, injection or other methods) to prevent the formation of malign cells and inflammation that causes irreversible damage.